References

Deep learning with differential privacy

2016 · External reference

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

10.1038/ncomms5006 · 2014 · External reference

Unresolved reference

2019 · External reference

A gentle introduction to conformal prediction and distribution-free uncertainty quantification

2021 · External reference

The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design

10.1513/annalsats.202003-192sd · 2020 · External reference

Statistical modeling of clinical trials (recruitment and randomization)

10.1080/03610926.2011.581189 · 2011 · External reference

10.1002/sim.2956

10.1002/sim.2956 · External reference

Recursive partitioning for heterogeneous causal effects

10.1073/pnas.1510489113 · 2016 · External reference

10.1080/00273171.2011.568786

10.1080/00273171.2011.568786 · External reference

An empirical evaluation of generic convolutional and recurrent networks for sequence modeling

2018 · External reference

Unresolved reference

External reference

Multimodal machine learning: a survey and taxonomy

10.1109/tpami.2018.2798607 · 2019 · External reference

10.18653/v1/d19-1371

10.18653/v1/d19-1371 · External reference

AstraZeneca-BenevolentAI collaboration productivity update. BenevolentAI FY2022/FY2023 Annual Reports

2022 · External reference

10.1038/nrd1927

10.1038/nrd1927 · External reference

Adaptive clinical trials: the promise and the caution

10.1200/jco.2010.32.2685 · 2011 · External reference

10.1007/s43441-020-00209-0

10.1007/s43441-020-00209-0 · External reference

Time series deconfounder: estimating treatment effects over time in the presence of hidden confounders

2020 · External reference

Unresolved reference

External reference

Practical secure aggregation for privacy-preserving machine learning

2017 · External reference

Applications of quantitative systems pharmacology in model-informed drug discovery: perspective on impact and opportunities

10.1002/psp4.12463 · 2019 · External reference

Random forests

10.1023/a:1010933404324 · 2001 · External reference

Generative adversarial networks in time series: a systematic literature review

10.1145/3559540 · 2023 · External reference

Multitask learning

10.1023/a:1007379606734 · 1997 · External reference

Fairness in machine learning: a survey

10.1145/3616865 · 2024 · External reference

Classification with fairness constraints: a meta-algorithm with provable guarantees

2019 · External reference

Anomaly detection: a survey

10.1145/1541880.1541882 · 2009 · External reference

Deep learning with multimodal representation for pancancer prognosis prediction

10.1093/bioinformatics/btz342 · 2019 · External reference

XGBoost: a scalable tree boosting system

2016 · External reference

Double/debiased machine learning for treatment and structural parameters

10.1111/ectj.12097 · 2018 · External reference

Unresolved reference

2017 · External reference

An economic approach to clinical trial design and research priority-setting

10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9 · 1996 · External reference

Unresolved reference

2014 · External reference

An economic perspective on platform trials—the gift and the curse

10.1001/jamanetworkopen.2022.21149 · 2022 · External reference

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods

10.1136/bmj-2023-078378 · 2024 · External reference

Real-world evidence and real-world data for evaluating drug safety and effectiveness

10.1001/jama.2018.10136 · 2018 · External reference

Unresolved reference

External reference

Federated learning for predicting clinical outcomes in patients with COVID-19

10.1038/s41591-021-01506-3 · 2021 · External reference

Unresolved reference

2019 · External reference

10.18653/v1/n19-1423

10.18653/v1/n19-1423 · External reference

Innovation in the pharmaceutical industry: new estimates of R&D costs

10.1016/j.jhealeco.2016.01.012 · 2016 · External reference

Using negative controls to identify causal effects with invalid instrumental variables

10.1093/biomet/asae064 · 2024 · External reference

The algorithmic foundations of differential privacy

10.1561/0400000042 · 2014 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2021 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

2025 · External reference

Unresolved reference

External reference

A survey of software tool utilization and capabilities for quantitative systems pharmacology: what we have and what we need

10.1002/psp4.12373 · 2019 · External reference

Unresolved reference

2023 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

2025 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

2011 · External reference

Launching PCORnet, a national patient-centered clinical research network

10.1136/amiajnl-2014-002747 · 2014 · External reference

10.1177/1740774509102310

10.1177/1740774509102310 · External reference

Greedy function approximation: a gradient boosting machine

2001 · External reference

A survey on concept drift adaptation

10.1145/2523813 · 2014 · External reference

Datasheets for datasets

10.1145/3458723 · 2021 · External reference

Unresolved reference

2013 · External reference

Unresolved reference

External reference

Radiomics: images are more than pictures, they are data

10.1148/radiol.2015151169 · 2016 · External reference

Peeking inside the black box: visualizing statistical learning with plots of individual conditional expectation

10.1080/10618600.2014.907095 · 2015 · External reference

Domain-specific language model pretraining for biomedical natural language processing

2021 · External reference

Unresolved reference

2020 · External reference

Group sequential tests for delayed responses (with discussion)

10.1111/j.1467-9868.2012.01030.x · 2012 · External reference

Equality of opportunity in supervised learning

2016 · External reference

Unresolved reference

2009 · External reference

Clinical development success rates for investigational drugs

10.1038/nbt.2786 · 2014 · External reference

Unresolved reference

External reference

Simulating study data to support expected value of sample information calculations: a tutorial

2021 · External reference

Unresolved reference

External reference

Bayesian nonparametric modeling for causal inference

10.1198/jcgs.2010.08162 · 2011 · External reference

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

10.7554/elife.26726 · 2017 · External reference

Dexamethasone in hospitalized patients with Covid-19

2021 · External reference

Observational health data sciences and informatics (OHDSI): opportunities for observational researchers

2015 · External reference

Unresolved reference

2020 · External reference

Unresolved reference

2019 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

2000 · External reference

Advances and open problems in federated learning

10.1561/2200000083 · 2021 · External reference

LightGBM: a highly efficient gradient boosting decision tree

2017 · External reference

10.1126/scitranslmed.3001807

10.1126/scitranslmed.3001807 · External reference

Parsable clinical trial eligibility criteria representation using natural language processing

2023 · External reference

10.1101/513945

10.1101/513945 · External reference

Unresolved reference

External reference

Can the pharmaceutical industry reduce attrition rates?

10.1038/nrd1470 · 2004 · External reference

Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system

10.1377/hlthaff.2014.0053 · 2014 · External reference

10.1073/pnas.1804597116

10.1073/pnas.1804597116 · External reference

Random-effects models for longitudinal data

10.2307/2529876 · 1982 · External reference

Radiomics: extracting more information from medical images using advanced feature analysis

10.1016/j.ejca.2011.11.036 · 2012 · External reference

BioBERT: a pre-trained biomedical language representation model for biomedical text mining

10.1093/bioinformatics/btz682 · 2019 · External reference

Developing a delivery science for artificial intelligence in healthcare

10.1038/s41746-020-00318-y · 2020 · External reference

Temporal fusion transformers for interpretable multi-horizon time series forecasting

10.1016/j.ijforecast.2021.03.012 · 2021 · External reference

A note on Platt’s probabilistic outputs for support vector machines

10.1007/s10994-007-5018-6 · 2007 · External reference

Modeling missing data in clinical time series with RNNs

2016 · External reference

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension

10.1038/s41591-020-1034-x · 2020 · External reference

10.1038/s42256-019-0138-9

10.1038/s42256-019-0138-9 · External reference

A unified approach to interpreting model predictions

2017 · External reference

Knowledge graphs and their applications in drug discovery

10.1080/17460441.2021.1910673 · 2021 · External reference

Portfolio selection

1952 · External reference

Unresolved reference

External reference

A survey on bias and fairness in machine learning

2021 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Learning from vertically distributed data across multiple sites: an efficient privacy-preserving algorithm for Cox proportional hazards model with variable selection

10.1016/j.jbi.2023.104581 · 2024 · External reference

Deep patient: an unsupervised representation to predict the future of patients from the electronic health records

10.1038/srep26094 · 2016 · External reference

Model cards for model reporting

2019 · External reference

Approaches to prioritising research for clinical trial networks: a scoping review

10.1186/s13063-022-06928-z · 2022 · External reference

Diagnostic verification of probability forecasts

10.1016/0169-2070(92)90028-8 · 1992 · External reference

Optimal dynamic treatment regimes

10.1111/1467-9868.00389 · 2003 · External reference

The support of human genetic evidence for approved drug indications

10.1038/ng.3314 · 2015 · External reference

Multimodal deep learning

2011 · External reference

Artificial intelligence in small-molecule drug discovery: a critical review of methods, applications, and real-world outcomes

10.3390/ph18091271 · 2025 · External reference

Unresolved reference

External reference

Continual reassessment method: a practical design for phase 1 clinical trials in cancer

10.2307/2531628 · 1990 · External reference

Open targets platform: supporting systematic drug-target identification and prioritisation

10.1093/nar/gkaa1027 · 2021 · External reference

Artificial intelligence in clinical trials: a comprehensive review of opportunities, challenges, and future directions

10.1016/j.ijmedinf.2025.106141 · 2026 · External reference

Discussion of trial designs for biomarker identification and validation through the use of case studies

10.1200/po.19.00051 · 2019 · External reference

How to improve R&D productivity: the pharmaceutical industry’s grand challenge

10.1038/nrd3078 · 2010 · External reference

Unresolved reference

2009 · External reference

On fairness and calibration

2017 · External reference

Apple watch, wearables, and heart rhythm: where do we stand?

10.21037/atm.2019.06.79 · 2019 · External reference

Unresolved reference

External reference

The future of digital health with federated learning

10.1038/s41746-020-00323-1 · 2020 · External reference

Unresolved reference

External reference

An overview of multi-task learning in deep neural networks

2017 · External reference

Sample-size formula for the proportional-hazards regression model

10.2307/2531021 · 1983 · External reference

Improving reproducibility by using high-throughput observational studies with empirical calibration

10.1098/rsta.2017.0356 · 2018 · External reference

Principles of large-scale evidence generation and evaluation across a network of databases (LEGEND)

10.1093/jamia/ocaa103 · 2020 · External reference

Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)

10.1016/j.drudis.2025.104291 · 2025 · External reference

Unresolved reference

2017 · External reference

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

2010 · External reference

A modern Bayesian look at the multi-armed bandit

10.1002/asmb.874 · 2010 · External reference

Hidden technical debt in machine learning systems

2015 · External reference

Artificial Intelligence and the future of clinical trials

10.1016/j.conctc.2025.101545 · 2025 · External reference

An update on knowledge graphs and their current and potential applications in drug discovery

10.1080/17460441.2025.2490253 · 2025 · External reference

Costs of drug development and research and development intensity in the US, 2000-2018

10.1001/jamanetworkopen.2024.15445 · 2024 · External reference

Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint

10.1038/s41598-024-80177-9 · 2024 · External reference

Deep EHR: a survey of recent advances in deep learning techniques for electronic health record (EHR) analysis

10.1109/jbhi.2017.2767063 · 2017 · External reference

Unresolved reference

External reference

A scoping review and assessment framework for technical debt in the development and operation of AI/ML competition platforms

10.3390/app15137165 · 2025 · External reference

10.1186/s12874-016-0272-6

10.1186/s12874-016-0272-6 · External reference

Unresolved reference

2018 · External reference

k-anonymity: a model for protecting privacy

10.1142/s0218488502001648 · 2002 · External reference

A scoping review of artificial intelligence applications in clinical trial risk assessment

10.1038/s41746-025-01886-7 · 2025 · External reference

Adaptive enrichment designs in clinical trials

10.1146/annurev-statistics-040720-032818 · 2022 · External reference

Semi-supervised classification with graph convolutional networks

2017 · External reference

On the likelihood that one unknown probability exceeds another in view of the evidence of two samples

10.1093/biomet/25.3-4.285 · 1933 · External reference

Regression shrinkage and selection via the Lasso: a retrospective

10.1111/j.1467-9868.2011.00771.x · 2011 · External reference

The personal and clinical utility of polygenic risk scores

10.1038/s41576-018-0018-x · 2018 · External reference

Comment: advancing clinical trials with novel designs and implementations

10.1214/23-sts865c · 2023 · External reference

Joint modeling of longitudinal and time-to-event data: an overview

2004 · External reference

Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: the Apple Heart Study

10.1016/j.ahj.2018.09.002 · 2019 · External reference

Unresolved reference

2011 · External reference

Unresolved reference

External reference

Machine learning for medical imaging: methodological failures and recommendations for the future

10.1038/s41746-022-00592-y · 2022 · External reference

Machine learning for medical imaging: methodological failures and recommendations for the future

10.1038/s41746-022-00592-y · 2022 · External reference

Unresolved reference

2023 · External reference

Decoding the genetic symphony: profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights

10.1093/pnasnexus/pgae011 · 2024 · External reference

10.1177/0272989x211068019

10.1177/0272989x211068019 · External reference

10.1186/s41512-019-0064-7

10.1186/s41512-019-0064-7 · External reference

Decision curve analysis to evaluate the clinical benefit of prediction models

10.1016/j.spinee.2021.02.024 · 2021 · External reference

Counterfactual explanations without opening the black box: automated decisions and the GDPR

2018 · External reference

Estimation and inference of heterogeneous treatment effects using random forests

10.1080/01621459.2017.1319839 · 2018 · External reference

Applications of deep learning in molecule generation and molecular property prediction

10.1021/acs.accounts.0c00699 · 2021 · External reference

Bayesian ordered lattice design for phase I clinical trials

2025 · External reference

I-SPY 2: a neoadjuvant adaptive clinical trial designed to improve outcomes in high-risk breast cancer

10.1007/s12609-019-00334-2 · 2019 · External reference

Doubly robust estimation in causal inference with missing outcomes: with an application to the Aerobics Center Longitudinal Study

10.1016/j.csda.2021.107399 · 2022 · External reference

Unresolved reference

External reference

Do no harm: a roadmap for responsible machine learning for health care

10.1038/s41591-019-0548-6 · 2019 · External reference

The FAIR guiding principles for scientific data management and stewardship

10.1038/sdata.2016.18 · 2016 · External reference

Marginal structural models in clinical research: when and how to use them?

10.1093/ndt/gfw341 · 2017 · External reference

Estimation of clinical trial success rates and related parameters

10.1093/biostatistics/kxy072 · 2019 · External reference

Master protocols to study multiple therapies, multiple diseases, or both

10.1056/nejmra1510062 · 2017 · External reference

Estimated research and development investment needed to bring a new medicine to market, 2009-2018

10.1001/jama.2020.1166 · 2020 · External reference

Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding

10.1093/annonc/mdx795 · 2018 · External reference

10.1158/1078-0432.ccr-16-0592

10.1158/1078-0432.ccr-16-0592 · External reference

10.1056/nejmsa1012065

10.1056/nejmsa1012065 · External reference

Robust variable selection methods with Cox model—a selective practical benchmark study

10.1093/bib/bbae508 · 2024 · External reference

10.1080/01621459.2012.695674

10.1080/01621459.2012.695674 · External reference

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

10.1038/s41587-019-0224-x · 2019 · External reference

10.1002/cpt.1475

10.1002/cpt.1475 · External reference

Modeling polypharmacy side effects with graph convolutional networks

10.1093/bioinformatics/bty294 · 2018 · External reference